Endometriosis News Home - Endometriosis News
News Endometriosis Common in Two-thirds of Women Affected by Infertility, Study Says Columns , Dachshunds & Duvets - a Column by Jessie Madrigal-Fletcher An Endometriosis Diagnosis Causes a Complex Emotional Response
What Is Endometriosis?
Endometriosis occurs when these womb cells develop elsewhere in the body. They go through the same monthly cycle, but have no outlet to leave the body once they break down. This causes inflammation (swelling) and potentially the formation of scar tissue in the affected areas. Causes of endometriosis. The exact cause of endometriosis is unknown.
About Us - Endometriosis News
Endometriosis News is neither promoting research nor involved in conducting any clinical trials. Some study summaries have been edited for clarity purposes to make them easier to understand. Note: Endometriosis News is strictly a news and information website about the disease.
What I Wish I'd Known About Laparoscopies - Endometriosis News
Jan 15, 2021 · Life with endometriosis involves at least one laparoscopy. Because adhesions can appear deep in the body, or hidden behind other organs, they often go undetected by imaging tests. This is why laparoscopies are the current standard when diagnosing the disease.
Gynecologists Praise Orilissa as Newest ... - Endometriosis News
Aug 10, 2018 · Read two leading gynecologists' opinions about Orilissa (elagolix), a new therapy aimed at relieving moderate-to-severe pain linked to endometriosis.
Endometriosis and Exercise - Endometriosis News
How exercise can alleviate the symptoms of endometriosis. Endometriotic lesions cause inflammation, which is thought to cause pain and fatigue. There are several mechanisms by which exercise can potentially reduce these two symptoms. Exercise stimulates the release of hormones called endorphins.
Relugolix - Endometriosis News
Relugolix (also known as Relumina, TAK-385, or RVT-601) is a gonadotropin-releasing hormone (GnRH) receptor antagonist being developed and tested by Myovant Sciences. This oral once-daily medicine is intended to treat endometriosis, as well as uterine fibroids and hormone-sensitive prostate cancer.
Uterine Fibroids - Endometriosis News
These abnormal endometrial-like cells swell and shed during menstruation just as normal endometrial cells do, but because they are not within the uterus, they cannot be expelled from the body normally. Fibroids are noncancerous growths …
Hormonal Therapy - Endometriosis News
Hormonal treatments aim to control or stop the monthly hormone cycle, often by reducing estrogen levels. This can prevent or slow the growth of the endometrial tissue, easing pain and inflammation. Different types of hormonal treatments can be …
Linzagolix (OBE2109) - Endometriosis News
Linzagolix (formerly OBE2109) is an experimental oral treatment being developed by ObsEva to ease symptoms of pain and heavy menstrual bleeding associated with endometriosis and uterine fibroids. The treatment was initially developed by Kissei Pharmaceutical.